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Background: Nearly all persons with dementia will experience neuropsychiatric symptoms (NPS) during the
course of their disease. Clinicians and researchers emphasize the need for an evidence-informed standardized
approach to managing NPS that integrates pharmacological and nonpharmacological treatments for real-world
implementation. The Targeted Interdisciplinary Model for Evaluation and Treatment of Neuropsychiatric Symptoms
(TIME) represents such an approach and is a multicomponent intervention based on the theoretical framework of
cognitive behavioural therapy.
Methods/design: The trial is a 3-month cluster randomized trial conducted in 30 nursing homes including 168
participants with dementia and a high level of agitation. Each nursing home defined as a cluster will be randomized to
receive either the TIME intervention (the intervention group) or a brief education-only intervention regarding
dementia and NPS (the control group). TIME is a manual-based, multicomponent programme that includes a
rigorous assessment, one or more case conferences and the treatment and evaluation of NPS. Patient-level
measurements are taken at baseline (prior to randomization) and 8 and 12 weeks later. The primary outcome
measure is the change in agitation, as defined by the Neuropsychiatric Inventory-Nursing Home Version, at 8
weeks from baseline. Secondary outcome measures include change in agitation at 12 weeks from baseline, and
change from baseline at 8 and 12 weeks in other NPS, quality of life, and the use of psychotropic and analgesic
medications. Mixed methods will be used to follow, measure and explore the implementation process and the
effect of the intervention at the individual staff level and the organization level. Combining measurements of
clinical effectiveness and implementation outcomes define this trial as an effectiveness-implementation hybrid trial.
Discussion: Measuring the implementation and effect of complex interventions aimed at reducing NPS in nursing
homes is challenging. In this study protocol, we describe a multicomponent program, TIME, and discuss how an
effectiveness-implementation cluster randomized hybrid trial can meet these challenges.
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In Norway, approximately 41,000 persons live in nurs-
ing homes, and more than 80 % of these have dementia
[1, 2]. Nearly 70 % of persons with dementia in nursing
homes exhibit clinically significant neuropsychiatric
symptoms (NPS)—also labelled as behavioural and psy-
chological symptoms of dementia (BPSD), such as
psychosis, depression, anxiety, agitation and apathy [3].
NPS like agitation, including physical or verbal aggres-
sion and excessive motor activity cause patients to ex-
perience profound suffering and a reduced quality of
life and caregivers to experience increased burden [4].
These symptoms represent great challenges in the care
of nursing home patients and are predictors of referral
to specialist health care and hospitalization [2, 5]. In a
review article published in 2014, a multidisciplinary
expert panel emphasized the need to develop compre-
hensive models for the assessment and treatment of
these symptoms. Such models should enable the sim-
ple implementation of these recommendations in real-
world settings [6].
A literature review by Livingstone et al. concluded
that behavioural therapeutic techniques and psychoedu-
cation aimed at altering the caregiver’s behaviour
seemed to reduce NPS [7]. However, the findings re-
garding other types of treatment were inconclusive and
inadequately documented. In a literature review that
Testad et al. performed in 2014 on personalized inter-
ventions targeting NPS the authors noted increasing
evidence that such interventions reduce NPS [8]. In a
controlled trial, Cohen-Mansfield et al. showed that a
systematic individual intervention based on a step-by-
step algorithm significantly reduced agitation. Unfortu-
nately, this study excluded patients exhibiting physical
aggression, and the research team implemented the
treatment measures in the wards [9]. Testad et al. con-
ducted a randomized intervention trial in nursing
homes in Norway and found that the systematic educa-
tion and supervision of staff resulted in a reduced use
of restraints although the level of agitated behaviour
remained unchanged or increased slightly [10]. A system-
atic review by Reuther et al. including 432 studies of case
conferences performed as interventions to address chal-
lenging behaviour concluded that four of seven studies in
the analysis showed a reduction in the challenging behav-
iour of people with dementia [11]. The review highlightedthe need for methodologically well-designed intervention
studies. A disadvantage of many of these interventions is
that they require a substantial amount of additional re-
sources to nursing homes to be implemented successfully.
A systematic review performed by Seitz et al. (2012) in-
cluded 40 studies on various interventions aimed at re-
ducing NPS. Sixteen studies showed positive results,
but 75 % of them required a significant increase in the
resources available to the nursing homes [12]. To our
knowledge no trials have used principles from cognitive
behavioural therapy (CBT) to structure care-delivery
interventions to manage NPS in nursing homes.The development of the TIME intervention
The Targeted Interdisciplinary Model for Evaluation and
Treatment of Neuropsychiatric Symptoms (TIME) was
developed in nursing homes by the first author, BL. This
model has been used in clinical practice in many nursing
homes since it was first developed in 2007–2008. It
requires minimal training, is manual based, and is easy
to integrate into everyday clinical practice and care with-
out major additional costs. The model is based on the
theoretical frameworks of cognitive behavioural therapy
(CBT) and person-centred care (PCC), which state that
human behaviour is subject to the continuous influence
of biological, social and psychological factors. Thus, the
model integrates pharmacological and nonpharmacologi-
cal treatments for real-world implementation. The pri-
mary purpose of the model is to allow an interdisciplinary
team of staff and physicians to conduct a thorough assess-
ment and critical systematic reflection in case conferences
to achieve a mutual understanding of NPS and, thereby,
implement customized actions based on this under-
standing. In 2010, The Centre for Old Age Psychiatric
Research, Innlandet Hospital Trust conducted an open
non-controlled trial in nine nursing homes over six
months and included 30 persons with dementia and
high levels of agitation. The results showed that pa-
tients’ agitation, mood symptoms and staff ’s distress
were significantly reduced. This study was published as
an abstract in International Psychogeriatrics [13] and
formed the basis for a revision of the TIME manual
[14] and a web-accessible short film that can be used
for training in the model [15]. In this abstract, the model
was referred to as the Multidisciplinary Intervention
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tients with Dementia (MIND).
Research aim and research questions
The primary purpose of this study is to improve the as-
sessment and treatment of agitation in persons with de-
mentia by examining the effect and implementation of
the TIME intervention model. We formulated the fol-
lowing research questions: 1) Can an intervention util-
izing TIME reduce agitation in persons with dementia
in nursing homes? 2) Does TIME serve as a method of
continuous learning and reflection? That is, can the
model help develop and strengthen staff members’ confi-
dence, mastery and competence at an individual level and
at an organizational level? 3) What nursing home factors




The first research question will be answered through a
cluster randomized controlled trial with two parallel
groups: Intervention Nursing Homes (INH) and Control
Nursing Homes (CNH). Fig. 1 shows a flow chart of the
clusters and individuals through the phases of the trial
based on the power calculation. For the second and
third research questions, we will utilise both quantitative
and qualitative methods. Data will be gathered from the
records of reflection meetings (case conferences) held
during the trial, implementation checklists completed
during the trial, four focus group interviews performedthe phases of the trial
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after the trial. The trial is defined as an effectiveness-
implementation cluster randomized hybrid trial because
of the use of various types of data and the study design.
Settings and target population
Municipalities located in the north, middle and south-
eastern part of Norway will be contacted to participate
in the trial. To ensure collaboration and implementation
throughout the trial, we will arrange meetings with the
health care leaders in the municipalities and the man-
agers and physicians working in each nursing home. We
will strive to recruit nursing homes located in both rural
and urban areas of Norway and to obtain an equal distri-
bution of large and small nursing homes to ensure a rep-
resentative nursing home population. Nursing homes
already using TIME as part of their clinical routines will
not be invited to take part in the trial.
All patients in wards in participating nursing homes
will be considered eligible for inclusion in the trial, and
will be assessed to determine if they meet the inclusion
criteria. Trained nursing home staff will perform the as-
sessments. The research team will train these staff mem-
bers on the inclusion procedure and the assessment of
patients’ capacity to provide consent. The data obtained
from screening individual eligible patients will not be re-
corded. Patients who fulfil the inclusion criteria and
agree to participate will be included in the trial. For pa-
tients who lack the capacity to provide consent, written
consent will be obtained from their next of kin.
The inclusion criteria for patients are as follows:
 NH patients with probable dementia, defined as a
Clinical Dementia Rating scale (CDR) [16] score of
one or higher.
 A moderate to high degree of agitation, defined by
an NPI-NH agitation item score equal to or above
six points.
 Long-term patients who have resided in the nursing
home for a minimum of two weeks before inclusion.
The exclusion criterion for patients is a life expectancy
of less than 4–6 weeks.
Sample size calculation based on the primary outcome
The primary outcome of the trial is the change in the
level of agitation from baseline at eight weeks, as mea-
sured by the agitation item of the Neuropsychiatric
Inventory-Nursing Home Version (NPI-NH) [17, 18].
Power calculation was based on the following assump-
tions. A previous non-controlled pilot study of TIME
showed that the intervention decreased the NPI-NH
agitation item score by on average 2.8, with a standard de-
viation (SD) for change of 3.1 [13]. One can reasonablyassume that the simple education-only intervention and
baseline and follow-up assessments may have some effect
on the control group. Therefore, we expect that the differ-
ence in the effect between the control and intervention
groups will be lower. We have assumed a mean difference
between the groups to be 1.5 as measured by NPI-NH agi-
tation item, and that this difference will have a SD of 3.1.
Based on this assumption, we calculate that 65 persons
must be included in each group to observe a statisti-
cally significant difference with a power of 80 % and a
significance level of 5 %. We assume an intra-cluster
(nursing home) correlation coefficient (ICC) of 0.05.
The ICC is assumed to be low because the persons in-
cluded will be located in different departments and
units in the nursing home (the cluster). Adjusting
power calculations for cluster effect, we find that at
least 78 persons have to be included in the intervention
group and 78 in the control group for the effect to be
statistically significant. That is, we need a total of 156
persons. Based on previous studies, we assume that the
average size of the nursing homes is 46 patients and
that each nursing home will recruit five patients, on
average. In the pilot study, we found that approximately
12 % of patients had dementia and an NPI-NH agita-
tion item score of six or higher, which is our main cri-
terion for inclusion. Previous studies have shown that
we can anticipate a 30 % loss to follow-up per year (due
to, e.g., mortality, relocation, or withdrawal from the
study)—that is, 7.5 % in three months. Thus, we will
need a total of 168 people (84 persons in each group),
indicating that we will need to screen approximately
1400 nursing home patients. Given approximately 46
patients on average per nursing home, we will need to
recruit approximately 30 nursing homes. The nursing
homes will be randomized after the baseline assessment
to avoid bias. The recruitment of new patients to the
study will therefore occur only through the recruitment
and randomization of new nursing homes, as described
above.
This study must perform cluster randomization, with
the nursing home as the cluster, for two main reasons.
The TIME intervention is a biopsychosocial intervention
that involves the entire interdisciplinary team and staff
in the wards of the participating nursing homes to
optimize the treatment provided to a group of patients
in the wards. In addition, the study runs the risk of
transmitting all or parts of the intervention model to the
control units or individual control patients at the same
nursing home [19].
Randomization
Nursing homes will be stratified by size into three blocks
to assure approximately equal number of patients in the
two trial arms. Block size will be fixed—block 1: 1–5
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patients. Then, nursing homes within each block will be
randomly assigned to either the intervention group or
the control group. A researcher will perform the
randomization procedure independently of the project
management team and the nursing homes. The project
management team will provide the nursing homes with
the randomization and allocation results immediately
following this procedure. Specially trained project nurses
who are not affiliated with the nursing homes will assess
patients’ baseline characteristics before randomization.
These assessors will also assess the effect of the inter-
vention via telephone at weeks eight and 12 and will be
blinded to the randomization result.
Control and intervention phases of the study
Similar education and training for the staff in CNH and
INH—CNH continue practice as usual
Three nurses in each unit in both the INH and CNH
will be given a special responsibility in the trial. Before
randomization, these nurses will complete a three-hour
training on the procedure. Their main task will be to fa-
cilitate the interviews for the assessments at baseline,
and after 8 and 12 weeks. These nurses will be selected
by the leading ward registered nurse based on the fol-
lowing criteria: nurses who work on a nearly full-time
basis, have shown interest in professional development
and have gained legitimacy with the rest of the staff.
Thus, these nurses can be selected among registered
nurses, auxiliary nurses, nursing aides or members of
other professional groups in the nursing homes.
After randomization, the staff in the INH and the
CNH will be offered a two-hour lecture about dementia
and NPS. This lecture represents the education-only
intervention administered to the staff in the CNH. These
staff members will then continue practice as usual for
the patients throughout the remainder of the trial.
Exclusive education and training of staff in the
INH—intervention utilizing TIME in the INH
In addition to the two-hour lecture about dementia and
NPS, the staff in the INH will complete three hours of
lectures, training and roleplay related to TIME. The edu-
cation and training team responsible for conducting the
education and training sessions consists of the project
management team (a physician with special competence
in nursing home medicine and two specialist registered
nurses in geriatrics) and four specialist registered nurses
in old age psychiatry, all of whom are familiar with
TIME. The lectures will be standardized according to
the steps listed in the TIME manual.
The leading ward registered nurse of each ward in the
INH will attend these lectures to ensure that this leading
nurse provide support to the staff during the trial. Wewill also encourage the nursing home physician to par-
ticipate. Each staff member in the INH will be provided
with the TIME manual, which describes the intervention
step by step. They will also be given access to an educa-
tional film about TIME and a website to support the
intervention. The three nurses who participated in the
coeducation for the inclusion criteria in each unit in the
INH will now hold the special responsibility for putting
the model into practice based on the manual. These
nurses will therefore receive three additional hours of
education, training and role play related to the different
components of TIME and the implementation of the
intervention. In the trial, they are referred to as TIME
administrators. Immediately after randomization and al-
location, the project management team will contact the
TIME administrators via telephone and instruct them to
begin to implement the intervention according to the
TIME manual for the patients included in the trial. This
telephone call is made from a few days up to 1 week be-
fore the education and training sessions are given. The
TIME manual is available online.
One specialist registered nurse from the education and
training team will attend and supervise the TIME ad-
ministrators’ first case conference on their first patient
in their nursing home. For the remainder of the TIME
intervention, and for the other patients included in the
trial, the TIME administrators and the staff will carry
out the intervention independently.
Description of the TIME intervention
The actual assessment and treatment programme for indi-
vidual patients is described in detail in the TIME manual,
which provides a step-by-step guide to implementing the
model. TIME consists of three overlapping phases: a regis-
tration and assessment phase; a guided reflection phase,
including one or more case conferences; and an action
and evaluation phase. These phases were adapted from
and based on problem-solving methods in CBT [20]
and are in line with reviews describing the “state of the
art” for the management of NPS [4, 6]. The different
components of TIME acting together thus provide an
evidence-informed standardized approach to managing
NPS.
In the registration and assessment phase, the nursing
home physician performs an examination of the patient
and the patient’s previous medical records and medica-
tions are critically reviewed. The staff gather personal
background information, pain is assessed, behaviour and
symptoms are registered in detailed 24-h daily records,
and behaviour and symptoms are monitored with estab-
lished clinical instruments, including the NPI-NH. This
phase is described in detail in Table 1. The duration of
this phase varies from one day up to 4 weeks, depending
on the nature and burden of the symptoms. Following
Table 1 The registration and assessment phase
Checklist for the registration and assessment phase of TIME
Activity Target symptoms:
Agree on the primary challenges for the patient using the Neuropsychiatric Inventory-Nursing Home Version (NPI-NH) to define precise target
symptoms for the assessment
Observation of the target symptoms using a 24-h observation form Staff Responsible
NPI-NH to assess other neuropsychiatric symptoms Staff
aCornell Scale of Depression in Dementia (CSDD) or another scale to assess
possible symptoms of depression
Staff
Physical assessment Nursing home physcian
Review of medication Nursing home physcian
bMobilisation-Observation-Behaviour-Intensity-Dementia Scale (MOBID-2) to assess
possible pain
Staff Nursing home physcian
The Clinical Dementia Rating Scale (CDR) and/or the cMini-Mental State
Examination (MMSE) to assess the dementia stage
Staff Nursing home physcian
dThe Physical Self-Maintenance Scale (PSMS) to assess activities in daily life Staff
Collection of resident life history, including preferences and resources, using an
optional questionnaire
Staff interview the resident (if possible)
and/or the next of kin
Make an appointment, i.e., set the date, time and place for the case conference Staff/TIME administrator
aCornell Scale of Depression in Dementia (CSDD) [26, 27]
bMobilisation-Observation-Behaviour-Intensity-Dementia Scale (MOBID-2) [45]
cMini-Mental State Examination (MMSE) [46]
dPhysical Self-Maintenance Scale (PSMS) [21]
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phase begins. In this stage, a case conference for the en-
tire group of staff, including the physician, is conducted.
Systematic reflection based on cognitive therapeutic
principles is carried out. The goal of this guided reflec-
tion is to create a mutual understanding of the actual
NPS of the patient and to tailor a detailed treatment
plan that will be tested in the coming weeks. The case
conference participants reflect on the situation using the
cognitive problem-solving method, in which one problem
is analysed at a time [20]. This reflection is performed sys-
tematically using a five-column sheet technique on a
whiteboard, and the following five aspects are reviewed:
assessed facts, interpretation, emotions, actions to take,
and evaluation. The time frame and the agenda for the
case conferences are outlined in Table 2. The last stage is
the action and evaluation phase. In this phase, each treat-
ment measure in the plan is put into action and is then
systematically evaluated with the same assessment tools
employed in the registration phase.
The time frame for the complete intervention with TIME
will vary from 1 or 2 weeks up to 8 weeks depending on
the severity and complexity of the NPS to be approached
and the resources available in the nursing homes.Procedures for data collection
The patients’ demographic data, baseline data and pri-
mary and secondary outcomes will be collected byproject nurses not affiliated with the nursing homes. All
10 assessors are nurses with substantial experience and
formal training on the use of the assessment scales. They
attended a one-day course on the use of the assessments
scales before start of the trial. The assessments of all
outcomes and covariates will be repeated at 8 and
12 weeks after baseline. The assessors will collect the
data via telephone by interviewing staff members who
know the patient best. The assessors will be blinded to
the randomization of the nursing homes. The following
data from patients’ medical records will be collected:
age, gender, marital status, type of ward the patient lives
in (regular somatic, special care units for dementia pa-
tients or other types), known diagnoses (chronic dis-
eases), and dementia diagnosis.
The following data describing the nursing homes will
be assessed by a questionnaire sent to the leading ward
registered nurse at the start of the trial: the size of the
nursing home (number of patients); the size of the unit
and ward (the number of patients per unit and ward);
the care factor (the number of nurses working per pa-
tient per work shift); the number of hours the nursing
home physician works per patient per week in the nurs-
ing home/unit; and the number of employees per leading
ward registered nurse.
Covariates that will be measured are: level of demen-
tia, as assessed by the CDR; level of functioning in daily
activities, as measured by the Physical Self-Maintenance
Scale (PSMS; [21]; and physical health, as measured by
Table 2 Agenda and time frame for the guided reflection meeting (case conference)
Agenda for guided reflection meeting (case conference) 1.5 h
Activity Preparation: Convene a meeting and prepare a meeting room
with a blackboard or similar facilities (projector, if available).
Check that a flip pad and markers are available
TIME administrators: Responsible
One is chairman for the meeting.
One takes notes on the whiteboard.
One writes the minutes on the 5-column sheet.
1. Status Report: Personal history and main points from the
patient’s medical record are presented.
10–
15 min
Decide in advance who should prepare and present
the patient’s personal history and the main points
from the medical record.
2. Create a problem list 10 min Staff (as many as possible should attend the
conference)
3. Prioritize problems from the list
4. Draw a 5−column sheet on the whiteboard: facts –
interpretations (thoughts) - emotions – actions – evaluation
60 min The leading registered nurse and the nursing home
physician should attend the conference, if possible.
5. Describe facts from the registration and assessment phase:
one problem at a time
6. Suggest interpretations – guided discovery – discuss and
reflect on them
7. Describe any emotions experienced by the staff – with
interpretations by the staff
8. Suggest aSMART actions – based on the interpretations –
decide how and when to perform an evaluation of the
actions
9. Summarize interpretations and actions – close the meeting 5–
10 min
TIME – administrator (chairman)
aSMART (Specific-Measurable-Actual-Realistic-Time framed)
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PSMS is a six-item scale that produces a sum score ran-
ging from 6 to 30. A higher score denotes more severe
functional impairment. GMHR is a one-item global rat-
ing scale with the categories good, fairly good, poor and
very poor.
Baseline data and primary and secondary outcome
measures
A full description of the screening instruments used to as-
sess the inclusion criteria and the primary and secondary
outcomes is provided in Table 3. The primary outcome of
the TIME trial is the difference in the change between
intervention and control group in agitation/aggression at
8 weeks from baseline, as measured by the NPI-NH [17].
The Norwegian version of the NPI-NH has shown high
inter-rater reliability and validity [23].
The secondary outcomes include the difference in the
change between the two groups in agitation/aggression
at 12 weeks from baseline, as measured by the NPI-NH,
in the change from baseline to 8 and 12 weeks in each
of the other items of the NPI-NH, the NPI-NH 10 sum
score, NPI-subsyndromal agitation score (aggression/
agitation + disinhibition + irritability), NPI-subsyndromal
psychosis score (delusion + hallucination) and affective
symptoms (depression + anxiety). These subsyndromes
are based on data from a previous principal componentanalysis [24]. The other secondary outcomes include
the difference between the two groups in the change from
baseline to 8 and 12 weeks in the following measures:
agitation, as measured by the Cohen-Mansfield Agitation
Inventory (CMAI; [25]; symptoms of depression, as mea-
sured by the Cornell Scale for Depression in Dementia
(CSDD); [26, 27]; drug use and dosage of psychotropic
and analgesic medications given both regularly and on
demand, coded as defined daily dosage (DDD) and
grouped according to the Anatomical Therapeutic
Chemical index [28]; and quality of life, as measured
by the Quality of Life in Late-stage Dementia Scale
(QUALID); [23, 29].
Qualitative and quantitative methods employed in the
trial to answer research questions 2 and 3
Focus group interviews
Focus group interviews will be conducted after the inter-
vention is completed. Four groups of five to eight care-
givers and leaders of the INH will participate. One
group of nursing home leaders, one group of TIME ad-
ministrators and two groups of caregivers from the staff
in different nursing homes will be arranged. Because of
group dynamics, the questions posed can be discussed
from several points of view. These dynamics can create
new perspectives and views during the discussion. We
will use an interview structure based on a semi-
Table 3 Primary and secondary outcome measures
What is measured (scales/tools) Characteristics and psychometric properties of scales/tools
Primary outcome measure: The difference between the intervention group and the control group in change from baseline at 8 weeks
Agitation/aggression (single item from the NPI-NH) Change from baseline of agitation and aggression, as defined by the Neuropsychiatric
Inventory-Nursing Home version (NPI-NH) item agitation/aggression. The NPI-NH assesses
the frequency (0–4) and the severity (0–3) of 12 psychiatric and behavioural symptoms.
An item score is generated by multiplying frequency and severity (0–12). A higher score
indicates more frequent and severe presence of NPS.
Secondary outcome measures: The difference between the intervention group and control group in change from baseline at 8 and 12 weeks
Neuropsychiatric symptoms (NPI-NH) 12 items described in the Neuropsychiatric Inventory Nursing Home Version (NPI-NH).
Range 0–12, as described above.
Subsyndrome of agitation (NPI-NH) The NPI-NH subsyndrome agitation is defined as the sum of the scores of the agitation/
aggression, irritability, and disinhibition items. Range 0–36.
Subsyndrome affective symptoms (NPI-NH) The NPI-NH subsyndrome affective symptoms is defined as the sum of the scores of
depression and anxiety items of the NPI-NH. Range 0–24.
Subsyndrome psychotic symptoms (NPI-NH) The NPI-NH subsyndrome psychosis is defined as the sum of the hallucinations and delusions
items. Range 0–24.
Neuropsychiatric symptoms (NPI-10 NH sum score) The NPI-10 NH sum score is the sum of the first ten items in the NPI-NH, omitting the sleep
disturbances and eating disorders (primarily vegetative symptoms) items. Range 0–120.
Caregiver occupational disruptiveness (NPI-NH) In NPI-NH, the caregiver must rate how disruptive they consider each behaviour or symptom
on a five-point scale. Range 0–5. A higher score indicates a more disruptive behaviour.
Agitation (CMAI) The Cohen-Mansfield Agitation Inventory (CMAI), which measures 29 different types of
agitation and the frequency at which they occur. Range for each item 1–7. Range total
score 29–203. A higher score indicates more frequent agitation. Good validity and inter-rater
reliability.
Depressive symptoms (Cornell) The Cornell Scale for Depression in Dementia, which measures the frequency of symptoms
of depression.
Quality of life (QUALID) Quality of Life in Late-stage Dementia Scale, which measures 11 behaviours rated on a
5-point Likert scale. Range 11–55. A lower score indicates higher quality of life. Good validity
and inter-rater reliability
Use and dosage of psychotropic and analgesic
medication (defined as daily dosage (DDD))
Psychotropic and analgesic medication given both regularly and on demand. This will be
assessed using a questionnaire and extracted from patients’ records. The assessment of
the medication given on demand will be obtained from patients’ records at each visit
and presented as the sum in mg used for the last 21 days. These drugs will be grouped
according to the Anatomical Therapeutic Chemical Index.
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on two main themes and follows up with open and ex-
ploratory questions posed by the interviewer [30]. These
two themes are 1) the feasibility of the intervention, with
an emphasis on the factors that promote or inhibit the
implementation of TIME, and 2) the effects that the
model has on learning and staff members’ experience of
coping and mastery of strain in the face of the challenging
behaviour of persons with dementia. If other key themes
emerge spontaneously during the interviews, time will be
allotted to develop these themes. Interviews will be
transcribed. A qualitative content analysis will be used
to explore the findings. Systematic text condensation
[31] will be performed to provide a systematic de-
scription and to develop new concepts and under-
standings of the phenomena. Researchers will identify
units in the text and then code and reorganize these
units repeatedly to emphasize the meaning content of
the data.Questionnaire surveys administered to the staff. Methods
evaluating the extent and duration of the implementation
of the model by use of the RE-AIM framework
A full description of the questionnaires, including re-
spondents and the time point(s) at which they are ad-
ministered, is provided in Table 4. The implementation
of TIME will be followed and assessed from the start of
the study to 1 year following the study based on the RE-
AIM framework [32]. RE-AIM is a widely used system
for following and evaluating interventions in organiza-
tions that aim to implement new methods of practice.
RE-AIM is an acronym for Reach, Efficacy, Adoption,
Implementation and Maintenance. In our trial, “Reach”
refers to the proportion of the staff participating in the
training, routine patient assessment, and subsequent
conference meetings. This information will be recorded
using a registration form to assess staff participation in
education and training sessions and a self-developed
questionnaire administered to the staff. “Efficacy” refers
Table 4 Questionnaires distributed to the staff and the leading ward registered nurse based on the RE-AIM-framework a for the
evaluation of complex interventions
What is assessed Questionnaire Corresponding dimension
of the RE-AIM framework
Time frame Respondents in the
nursing homes (NH)
Proportion of staff members
participating in education and
training sessions
A registration form to assess
participation of staff in
education and training sessions
Reach: proportion of staff in
INH that actually participated
in the intervention during the
trial
At the start of the
intervention during
education sessions
All staff members in
intervention nursing
homes (INH)
Individual participation of staff
members in effectuating the
components of the model
Self-developed questionnaire Reach: as above Maintenance:
extent to which the model is
sustained over time
6 and 12 months after
the start of the
intervention
All staff members in
INH
Attitudes towards persons with
dementia, mastery, social




Approaches to the Dementia
Questionnaire b, QPS-Nordic c
and a self-developed question-




attitudes of the staff in NH
1 month before, and 6
and 12 months after the
start of the intervention
All staff members in
control nursing homes
(CNH) and in INH
Clinical routines in place in
NH, i.e., questions assessing
daily routines of practice for




best practice for assessment and
treatment of NPS
Adoption: proportion of
wards that will adopt the
intervention Maintenance:
extent to which the model is
sustained over time
1 month before and 6
and 12 months after the
start of the intervention
Leading ward
registered nurse in INH
and CNH
Fidelity to the main
components in the model
Interview of TIME administrators
by telephone using a checklist
based on the components in
the TIME manual
Implementation: extent to
which the intervention is
actually implemented
3 brief interviews, the
first one 3 weeks after
the start of the




Organizational structure in the
nursing homes: size of wards,
type of unit, number of staff,
etc.




At the start of the
intervention
Leading ward
registered nurse in INH
and CNH
aRE-AIM framework: Reach-Efficacy-Adoption-Implementation-Maintenance [32]
bGeneral Nordic Questionnaire for Psychological and Social Factors at Work (QPS-Nordic) [33]
cApproaches to Dementia Questionnaire (ADQ) [34]
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of attitudes, mastery, knowledge and skills, which we will
assess and analyse using data from the focus group inter-
views and questionnaires. The following questionnaires
will be administered for this purpose: the General Nor-
dic Questionnaire for Psychological and Social Factors
at Work regarding mastery and social interaction
(QPS-Nordic) [33], the Approaches to Dementia Ques-
tionnaire (ADQ) [34], and a brief self-developed ques-
tionnaire assessing perceived competence regarding
NPS. Both QPS-Nordic and ADQ are validated ques-
tionnaires used to assess these domains.
In this type of intervention, “Adoption” refers to the
proportion of wards and the percentage of the staff
who actually adopt this method to manage NPS. We
will use data from the focus group interviews and a
self-developed questionnaire about participation in the
routines of practice in the unit. “Implementation” refers
to whether the intervention is carried out at the
organization level as planned and with integrity. It will
be assessed with a checklist once per month for 3
months after the start of the intervention. The checklist
includes only the main components of the interventionderived from the checklist in the TIME manual. “Main-
tenance” refers to the degree to which the organization
succeeds in maintaining the intervention after the pro-
ject period. Maintenance will be measured with a self-
developed questionnaire administered to units at 6 and
12 months after the intervention is implemented. This
questionnaire will assess the extent to which the model
and its components continue to be systematically applied.
To answer the question of which factors inhibit or pro-
mote implementation, we will analyse the data from the
focus group interviews and from the questionnaires.Data processing and statistical analysis of quantitative
data
All data regarding the cluster randomized trial will be
collected via telephone. The data will be registered on-
line in the dataset prepared for the study using the data
tool Checkbox via a web survey to the SQL database.
The questionnaires used to collect all other data will be
distributed to staff (regardless of job position) by mail
and the results will be stored in the same manner as
the trial data. At the 6- and 12-month assessments,
Lichtwarck et al. BMC Psychiatry  (2016) 16:233 Page 10 of 12questionnaires will be sent only to the staff who
responded to the previous questionnaires.
The data will be presented as frequencies and per-
centages for categorical and means (standard devia-
tions) for the continuous variables. The normality of
continuous variables will be assessed graphically. If ne-
cessary, skewed data will be transformed. Differences in
the changes in outcomes between the intervention
group and the control group will be assessed by a linear
mixed model with fixed effects for time component and
group and the interaction between the two. A signifi-
cant interaction will imply the differences in change be-
tween the groups. Random effects for patients nested
within nursing homes and slopes (if significant) will be
included into the model. Individual time point con-
trasts will be derived within each group at each time
point with the corresponding 95 % confidence intervals
and p-values. Linear mixed model correctly adjusts esti-
mates for intra-cluster correlations as well as for intra-
individual correlations due to repeated measurements
in time. The model also handles unbalanced data by
allowing inclusion of all available information, also
from drop-outs.
Trial status
The cluster randomized trial will be carried out from
January to the end of June 2016.
Focus groups will be held in September and October
2016. The part of the trial evaluating the implementation
process started in December 2015 and continue until
the end of April 2017.
Discussion
The main purpose of this trial is to improve the assess-
ment and treatment of agitation in persons with demen-
tia by examining the effect and implementation of the
TIME intervention model. The strength of the model is
that it was developed in nursing homes over a period of
several years; thus, it takes into account the nursing
home context. A pilot study showed its feasibility and
further developed the model [13]. The model integrates
pharmacological and nonpharmacological treatments for
use in real-world implementation. The components of
the model have a solid theoretical foundation [6, 20, 35].
Given that NPS often represent complex problems with
multifactorial causes that interact with each other, often
in unpredictable ways, multifaceted and complex inter-
ventions must be applied.
One of the challenges of psychosocial interventions is
effectively and sustainably implementing them. Fixsen de-
fined implementation as a specific set of activities com-
bined in practice to introduce an activity or a programme
with known components. Similar to an actual intervention
(programme or model), implementation includes a set ofactivities and a set of outcomes [36]. Richards and
Hallberg defined complex interventions as “Activities
that include multiple components with the potential
for interactions between them. When such an interven-
tion is applied to the target population a number of
possible and varied results are created” [37]. Based on
this description, we claim that TIME satisfies the defin-
ition of a complex intervention [14]. An intervention’s
complexity must also be considered based on the
context—that is, the type of organization and the orga-
nization’s various participants [38]. A lack of an effect
may reflect the failure of implementation rather than
shortcomings of the implemented programme or model
[38]. Therefore, the implementation of complex interven-
tions is particularly demanding.
The Medical Research Council (MRC) defines an
overarching framework for the development and evalu-
ation of complex interventions. This recommendation
was revised in 2008 to place greater emphasis on the
importance of the process evaluation and adaptation to
local contextual conditions compared with the previous
recommendations [39]. In our trial, we will follow these
recommendations and simultaneously apply an experi-
mental design for measurements of effectiveness at the
patient level and conduct an experimental evaluation of
the implementation. Our reports on the TIME trial will
follow the recommendations presented in the CON-
SORT 2010 statement: extension to cluster randomized
trials [40].
A design that combines clinical effectiveness and
implementation outcomes in one trial is called an
effectiveness-implementation hybrid design [41, 42].
The main advantage of this hybrid design is that it can
accelerate the translation of research findings into
routine practice. It also allows the research team to
evaluate the results regarding effectiveness in light of
the degree of fidelity and adoption of the model. For
this advantage to be realized, the implementation
strategies in the trial cannot be overly complex. Thus
the implementation strategies should not demand
basic structural changes within the organization re-
ceiving the intervention. Although TIME is a complex
intervention, we experienced during the pilot study
that the intervention does not require significant
changes within the organizations’ structures or rou-
tines, and the implementation costs were estimated to
be low.
Our study design has some limitations. We do not re-
quire a precise diagnosis of dementia as an inclusion
criterion; instead, we include patients with probable de-
mentia, defined as a CDR score of one or higher. A pre-
vious study on a Norwegian NH showed that only
approximately one-third to one-half of residents with
dementia were assessed and given a diagnosis of
Lichtwarck et al. BMC Psychiatry  (2016) 16:233 Page 11 of 12dementia [1, 43]. In addition, several studies have
shown that CDR staging based solely on an informant
interview is a valid substitute for patient examinations
[43, 44]. Therefore, even if a few patients included in
our study do not fulfil all the criteria for a dementia
diagnosis, the use of the CDR as a criterion for inclu-
sion instead of a precise diagnosis of dementia will
strengthen the external validity of our findings. Another
limitation is the rather short follow-up time. The last
visit in which the patient outcomes will be assessed is
the 12-week visit, primarily due to resource limitations
and to ensure staff compliance. To be considered clin-
ically important, an intervention aimed at reducing
NPS should show some measurable effects after 8 to
12 weeks. The data collection concerning the imple-
mentation process will nevertheless span a year to
measure the sustainability of the intervention.
Conclusion
The increasing percentage of the population with de-
mentia will be a major challenge for health and care fa-
cilities in the coming years. Nearly all people who
suffer from dementia experience NPS in the course of
their disease. NPS like agitation, including physical or
verbal aggression and excessive motor activity cause pa-
tients to experience profound suffering and a reduced
quality of life and caregivers to suffer increased burden
[4]. TIME is a multicomponent intervention based on the
theoretical framework of CBT. The TIME trial is an
effectiveness-implementation cluster randomized trial
designed to assess both effects on NPS in persons with de-
mentia residing in nursing homes and the implementation
process at the staff and organization levels. An open pilot
study conducted in 2010 showed that the intervention is
feasible and found a reduction in patients’ agitation and
mood symptoms and caregiver strain. The trial will take
place in 30 nursing homes and will include 168 patients
with dementia and a high degree of agitation. The aim of
this project is to make an important contribution to im-
prove the treatment of NPS. Furthermore, the project may
result in an evidence-based model for assessment and
treatment in both primary care and specialist care. The
project will provide additional insight into how to sustain-
ably implement complex interventions.
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